Thank you
I hope to get some responses too - perhaps within the next week or two please!
Kind Regards
Jessica
-----Original Message-----
From: ACB AKI-Detection-Algorithm [mailto:[log in to unmask]] On Behalf Of Hill Robert (NORTH BRISTOL NHS TRUST)
Sent: 10 October 2014 21:14
To: [log in to unmask]
Subject: Re: AKI interpretation
---
This message was sent from an email address external to NHSmail but gives the appearance of being from an NHSmail (@nhs.net) address. The recipient should verify the sender and content before acting upon information contained within.
The identified sender is [log in to unmask]
---
Thank you for the question Jessica. I hope mailbase members will respond to this. I shall contribute when the debate has run for a little while. Do you want to put a deadline date for responses?
Dr Robert Hill
Consultant Clinical Biochemist
________________________________________
From: ACB AKI-Detection-Algorithm [[log in to unmask]] On Behalf Of Schroeder, Jessica (WRH Biochemistry Medical Staff) [[log in to unmask]]
Sent: 10 October 2014 15:38
To: [log in to unmask]
Subject: AKI interpretation
To all AKI mailbase members
We are interested to know whether labs that have implemented AKI alerts have any 'manual' interpretation steps to ensure the validity of AKI comments or alerts. I understand that the algorithm is not designed to be 'perfect', as AKI is a clinical diagnosis. But I am concerned about automatically sending out a comment in certain scenarios, for example... Is it appropriate to put AKI comments in cases where previous creatinine results may relate to an inpatient episode (with perhaps fluid changes affecting the creatinine) or in cases where previous creatinine results may have been during pregnancy.
Is it always appropriate to put AKI comments in patients who have shown a change from creatinine 50 to 76??
Is there a risk of too many 'false positives' being reported, leading to 'alert fatique'.
Following the AKI meeting in Birmingham, I understand that the National Programme aims to send 'AKI' alerts direct to a regional/national AKI register. Is there a danger that some patients may be mislabelled as 'AKI'?
We would be interested in learning from the experience of other labs nationally.
Many thanks in advance for any comments
Jessica
Jessica Schroeder
Principal Biochemist
Worcestershire Acute NHS Trust
Unless expressly stated otherwise, the information contained in this email is confidential and is intended only for the named recipients. You must not copy, distribute, or take any action or reliance upon it. If you have received this email in error, please notify the sender. Any unauthorised disclosure of the information contained in this email is strictly prohibited.
********************************************************************************************************************
This message may contain confidential information. If you are not the intended recipient please inform the sender that you have received the message in error before deleting it.
Please do not disclose, copy or distribute information in this e-mail or take any action in reliance on its contents:
to do so is strictly prohibited and may be unlawful.
Thank you for your co-operation.
NHSmail is the secure email and directory service available for all NHS staff in England and Scotland NHSmail is approved for exchanging patient data and other sensitive information with NHSmail and GSi recipients NHSmail provides an email address for your career in the NHS and can be accessed anywhere
********************************************************************************************************************
Unless expressly stated otherwise, the information contained in this email is confidential and is intended only for the named recipients. You must not copy, distribute, or take any action or reliance upon it. If you have received this email in error, please notify the sender. Any unauthorised disclosure of the information contained in this email is strictly prohibited.
|